Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Pharmaceutical studies and practices
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on the developmental pharmacology and pediatric drug use, including topics such as off-label drug use, adverse drug reactions, clinical trials, pediatric formulations, medication adherence, regulatory framework, and neonatal intensive care. It addresses the challenges and considerations specific to drug disposition, action, and therapy in infants and children.
220
Works
IDs:OpenAlex
How has Pharmaceutical studies and practices's publication output changed over time?
ScholarIQpublication output · 2000–2021
Output grew0% over the shown period — from 1 works in 2000 to 1 in 2021.
1
2
1
1
1
1
2
2
1
1
2000200420082009201120122013201520172021
What are the most-cited papers on Pharmaceutical studies and practices?
ScholarIQmost cited works
Standard 6: Age Groups for Pediatric Trials
Katrina Williams, Denise Thomson, Iva Seto, Despina G. Contopoulos‐Ioannidis, John P. A. Ioannidis, Sarah Curtis, Evelyn Constantin, Gitanjali Batmanabane, Lisa Hartling, Terry P. Klassen
PEDIATRICS. 2012543 Citations
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].
Jean‐Paul Boissel, Michel Cucherat, Wei Li, Gilles Châtellier, François Gueyffier, Marc Buyse, Florent Boutitie, Patrice Nony, M. Haugh, G Mignot
PubMed. 2000534 Citations
Drug dosing consideration in patients with acute and chronic kidney disease—a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
Gary R. Matzke, George R. Aronoff, Arthur J. Atkinson, William M. Bennett, Brian S. Decker, Kai‐Uwe Eckardt, Thomas A. Golper, Darren W. Grabe, Bertram L. Kasiske, Frieder Keller, Jan T. Kielstein, Ravindra L. Mehta, Bruce A. Mueller, Deborah A. Pasko, Franz Schaefer, Domenic A. Sica, Lesley A. Inker, Jason G. Umans, Patrick Murray
Kidney International. 2011458 CitationsOPEN ACCESS
Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use
S. Swaroop Vedula, Lisa Bero, Roberta W. Scherer, Kay Dickersin
New England Journal of Medicine. 2009367 Citations
Where is Pharmaceutical studies and practices research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Pharmaceutical studies and practices is open access?
ScholarIQopen access share
33%OPEN ACCESS
Gold
7%
Green
20%
Hybrid
7%
Bronze
0%
Closed
67%
Related on ScholarIQ
A new taxonomy for describing and defining adherence to medications
Paper
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis
Paper
Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.
Paper
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Paper
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
Paper
Pharmacogenetics: From Bench to Byte— An Update of Guidelines
Paper